These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 570900)

  • 1. Bromocriptine treatment of seven women with primary amenorrhoea and prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):145-54. PubMed ID: 570900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine treatment of hyperprolactinaemic hypogonadism.
    Thorner MO; Besser GM
    Acta Endocrinol Suppl (Copenh); 1978; 216():131-46. PubMed ID: 347858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprolactinaemia in amenorrhoea - incidence and clinical significance.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):683-94. PubMed ID: 335758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia in cases of infertility and amenorrhea.
    Furuhjelm M; Rydner T; Carlström K
    Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bromocriptine-induced pregnancy on prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Larsson SG; Wide L
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):333-8. PubMed ID: 7293665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hyperprolactinaemic amenorrhoea.
    Franks S; Jacobs HS; Hull MG; Steele SJ; Nabarro JD
    Br J Obstet Gynaecol; 1977 Apr; 84(4):241-53. PubMed ID: 870009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
    Jacobs HS; Franks S; Murray MA; Hull MG; Steele SJ; Nabarro JD
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):439-54. PubMed ID: 825329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pregnancy and lactation on pituitary prolactin-secreting tumours.
    Zárate A; Canales ES; Alger M; Forsbach G
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):407-12. PubMed ID: 517046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and significance of hyperprolactinaemia in women with amenorrhea.
    Franks S; Murray MA; Jequier AM; Steele SJ; Nabarro JD; Jacobs HS
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):597-607. PubMed ID: 1104218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.
    Nillius SJ; Bergh T; Lundberg PO; Stahle J; Wide L
    Fertil Steril; 1978 Dec; 30(6):710-2. PubMed ID: 729834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactinomas presenting as primary amenorrhoea and delayed or arrested puberty: response to medical therapy.
    Howlett TA; Wass JA; Grossman A; Plowman PN; Charlesworth M; Touzel R; Rees LH; Savage MO; Besser GM
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):131-40. PubMed ID: 2612015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation and management of symptomatic hyperprolactinaemia.
    Holdaway IM; Frengley PA; Mountjoy KG; Ibbertson HK; Graham FM; France JT
    Aust N Z J Obstet Gynaecol; 1979 May; 19(2):100-6. PubMed ID: 292425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of patients with prolactinomas after discontinuation of long-term therapy with bromocriptine.
    Zárate A; Canales ES; Cano C; Pilonieta CJ
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):139-42. PubMed ID: 6356741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperprolactinemic amenorrhea. Clinical relevance, endocrine features, therapy (author's transl)].
    Rjosk HK; Werder K; Fahlbusch R
    Geburtshilfe Frauenheilkd; 1976 Jul; 36(7):575-87. PubMed ID: 986336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients with hyperprolactinemia and normal or abnormal tomograms.
    Kletzky OA; Marrs RP; Davajan V
    Am J Obstet Gynecol; 1983 Nov; 147(5):528-32. PubMed ID: 6638094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.